Jump to content

Federal Court Of Appeals To Consider The Benefits Of Medical Marihuana


Recommended Posts

Here are the Summary of the arguments

 

THE DEA ACTED ARBITRARILY AND CAPRICIOUSLY, AND WITHOUT SUBSTANTIAL EVIDENCE, IN CONCLUDING THAT MARIJUANA DOES NOT HAVE A “CURRENTLY ACCEPTED MEDICA USE IN TREATMENT IN THE UNITED STATES”

 

 

QUALIFIED EXPERTS RECOGNIZE THAT MARIJUANA HAS MEDICAL USE

 

THE DEA ERRED IN FAILING TO FIND THAT MARIJUANA’S CHEMISTRY IS KNOWN AND REPRODUCIBLE

 

THE DEA AND HHS ERRONEOUSLY FAILED TO COMPARE MARIJUANA TO OTHER SCHEDULED SUBSTANCES

THE DEA ERRONEOUSLY EQUATES US OF MARIJUANA WITH A “HIGH” POTENTIAL FOR ABUSE

 

THE DEA AND HHS ERRONEOUSLY FAILED TO COMPARE MARIJUANA TO OTHER SCHEDULED SUBSTANCES

 

QUALIFIED EXPERTS RECOGNIZE THAT

THE DEA ERRED IN FAILING TO FIND THAT MARIJUANA’S CHEMISTRY IS KNOWN AND REPRODUCIBLE

THE DEA AND HHS ERRONEOUSLY FAILED TO COMPARE

 

MARIJUANA TO OTHER SCHEDULED SUBSTANCES

THE DEA ERRONEOUSLY EQUATES US OF MARIJUANA WITH A “HIGH” POTENTIAL FOR ABUSE

THE DEA AND HHS ERRONEOUSLY FAILED TO COMPARE MARIJUANA TO OTHER SCHEDULED SUBSTANCES

 

RESPONDENTS ABUSED THEIR DISCRETION IN DENYING PETITIONERS A HEARING AFTER STALLING ON THEIR DENIAL OF T HE RESCHEDULING PETITION FOR NEARLY TEN

YEARS

 

http://blogs.wsj.com/law/2012/10/08/appeals-court-to-consider-theraputic-value-of-medical-marijuana/

 

http://safeaccessnow.org/downloads/ASA_v_DEA_Reply_Brief.pdf

 

 

Michael A. Komorn

Attorney and Counselor

Law Office of Michael A. Komorn

3000 Town Center, Suite, 1800

Southfield, MI 48075

800-656-3557 (Toll Free)

248-351-2200 (Office)

248-357-2550 (Phone)

248-351-2211 (Fax)

 

Email: michael@komornlaw.com

Website: www.komornlaw.com

 

Check out our Radio show:

http://www.blogtalkradio.com/planetgreentrees

CALL IN NUMBER: (347) 326-9626

Live Every Thursday 8-10:00p.m.

 

PLANET GREENTREES

w/ Attorney Michael Komorn

 

The most relevant radio talk show for the Michigan Medical Marijuana Community. PERIOD.

Link to post
Share on other sites

It only took the DEA eleven years to hear and rule on the petition that Francis Young, that was concluded in 1988, found to be positive toward the efficiacy of the substance as a drug in medical applications.

Edited by GregS
Link to post
Share on other sites

It only took the DEA eleven years to hear and rule on the petition that Francis Young, that was concluded in 1988, found to be positive toward the efficiacy of the substance as a drug in medical applications.

 

I don't see you here very often these days, it was nice to read you.

Link to post
Share on other sites

A ruling that the current scheduling is erroneous and that there needs to be hearings, could send the DEA into overtime to get hearings taking place ASAP.

 

In that case, I believe there would be no federal marijuana law. It HAS happened before.

 

That is, after the tax stamp act was found unconstitutional, there was a period where there was no federal marijuana law. It took time to make the new Controlled Substance Act.

Edited by peanutbutter
Link to post
Share on other sites

I think they may find that it doesn't belong in schedule one but it is up to HHS, FDA and DEA to hold hearings to determine where it DOES belong.

 

Leaving marijuana completely off the schedule system until the hearings DO take place.

 

There are major tax differences between schedule 2 and 3. The IRS action against Harborside would still be taking place if it was put into schedule 2.

Edited by peanutbutter
Link to post
Share on other sites

I think they may find that it doesn't belong in schedule one but it is up to HHS, FDA and DEA to hold hearings to determine where it DOES belong.

 

Leaving marijuana completely off the schedule system until the hearings DO take place.

 

There are major tax differences between schedule 2 and 3. The IRS action against Harborside would still be taking place if it was put into schedule 2.

Just curious how DEA has any credability in the say so. Like where do they get any legitamate expertise, especially since they have done everything ever concieved possible to prevent any studies, research or trials to clarify this. Including terrorizing inquisitive the brave citizens that tried to better their lives with beneficial herbs v addictive poisonous pharmacueticals.

 

They were created to police the " druggies " with over the top military type tacticts. They are irrelevant to the discussion. imho

Link to post
Share on other sites

I am not saying we shouldn't, just saying that it could subject the doctor to more scrutiny. I don't understand how a doctor would go about recommending a schedule II controlled substance when they think a prescription is required to obtain it. There are just some unknowns, that is all I am saying.

 

I envision parallel systems. Our Docs here in MI have a lot of protection under the Act.

Link to post
Share on other sites

There are seventeen regulation schemes that states have produced.

 

EVERYTHING about marijuana doesn't fit into the regular scheduling model.

 

To adjust the federal model would require the fed policy match each state policy.

 

If it moves at all it, should be dropped entirely from federal law.

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
  • Similar Content

    • By Michael Komorn
      Hemp, Inc. (OTC: HEMP), the first all-hemp, publicly-traded company in US history forges path in the industrial hemp industry, continues its effort to blow the lid off a nest of deception and double standards many feel have been imposed by the United States government concerning the ancient superfood, hemp seeds. Despite the Cannabis classification, hemp seeds aren't for smoking, nor does it get you "high" as countless people have been led to believe, according to the Kimble Group, LLC. Hemp seeds are growing in popularity, thus, questions are arising concerning their presumed health benefits. So what is it 'they' don't want the American people to know? Why would such enlightening, useful and beneficial information be kept under wraps?
      http://www.prweb.com/releases/hemp/marijuana/prweb9954724.htm
       
       
       
      The first all-hemp, publically-traded company in US History,Hemp, Inc. (OTC: HEMP), hemp.com, blows the lid off a nest of deception.
      (PRWEB) September 28, 2012
       
      It wasn't until this year, August, US senators Jeff Merkley, Ron Wyden, Bernie Sanders and Rand Paul ardently worked together in a bipartisan effort to get industrial hemp removed from the federal doghouse. If passed, this historic senate bill will create economic opportunities by removing federal restrictions on the domestic cultivation of industrial hemp.
      Before light is shed on the benefits on hemp, let's take a look at how and why hemp has been getting a bad rap over the years. According to Hemp, Inc. (OTC: HEMP), the first all-hemp, publically-traded company in US history, William Hurst, an influential American newspaper publisher, created a yellow journalism campaign to associate hemp with marijuana. Why?
      Commercial hemp seeds contain very low amounts of THC, the property responsible for the drug response, plus they contain a substance that counteracts THC. According to Dr. David P. West, who specializes in plant breeding and genetics and who has written a plethora of articles on industrial hemp, says, "The washed hemp seed contains no THC at all. The tiny amounts of THC contained in industrial hemp are in the glands of the plant itself. Sometimes, in the manufacturing process, some THC- and CBD-containing resin sticks to the seed, resulting in traces of THC in the oil that is produced. The concentration of these cannabinoids in the oil is infinitesimal. No one can get high from it."
      Hurst, along with his friend Pierre DuPont, succeeded in outlawing hemp in America and in turn robbed the world of an environmental cash crop. Why would they do such a thing? As noted by Hemp.com, "Because instead of using hemp for paper, clothing, fuel, oils, resins, medicines, and many other uses, we now use trees and synthetic petrochemicals. Hearst owned huge forests and interests in lumber mills. DuPont made synthetic fuels and fibers (nylon, rayon, plastics) from petroleum." Go figure.
      Hemp seeds go back as far as 8,500 years. Initially, the Chinese were harvesting it and using the plant fibers to produce durable cloth, however, 3,000 years ago, they began using the seeds as a food source. Hemp seeds have been a proven source of protein on the planet, primarily because they contain all twenty one known amino acids.
      Clinical herbalist, Larken Bunce, says, "Hemp seeds are a nutritionally dense food source that provide the body with necessary macro- and micronutrients, including protein, essential fatty acids, fiber, vitamins and minerals. The addition of hemp seeds to your daily diet can ensure you are getting necessary essential fatty acids, a good balance of protein and carbohydrates, a good source of fiber as well as some essential vitamins and minerals."
      Essentially, the human organism is unable to produce all essential amino acids, but amazingly, hemp does. The hemp seeds are a great source of polyunsaturated fat as well as essential fatty acids. According to Nourishing Gourmet, hemp foods are also a rich source of phytonutrients, the organic compounds of plants that are thought to promote human health.
      More specifically, Dr. Cassandra Forsyth, nutrition researcher at the University of Connecticut, says, "Hemp seeds are rich in omega3 fatty acids, which reduce your risk of heart disease and stroke." According to an article in Men's Health, written by Carolyn Kylstra on 9/25/12, a 1-ounce serving of the seeds provides 11 grams of protein, not to be confused with incomplete protein found in most plant sources. The article's research found the protein in hemp seeds to be comparable to that found in meat, eggs, and dairy.
      If hemp food is easily digested and in turn can be used to treat malnourishment, why such a bad rap? Why not mass produce since the consumption of complete proteins is necessary for human survival? The US Government's complacency of 'profit before health' can no longer stand on the incredulous foundation on which it was built. The American people are, indeed, waking up.
       
      Michael A. Komorn
      Attorney and Counselor
       
      Email: michael@komornlaw.com
      Website: www.komornlaw.com
       
      Check out our Radio show:
      http://www.blogtalkradio.com/planetgreentrees
       
      Live Every Thursday 8-10:00p.m.
       
      PLANET GREENTREES
      w/ Attorney Michael Komorn
       
      The most relevant radio talk show for the Michigan Medical Marijuana Community. PERIOD
    • By Michael Komorn
      Great Show last night- we had the world renowned leading specialist in the human cannabinoid system Dr. William Courtney. If you want to learn about the health benefits of Raw Juicing the cannabis plant, this is the show you want to listen to. (Dr. Courtney and the Medical Cannabis Communities favorite Legislature Representative Callton will be speaking tonight Friday 10 12 12 at the Genesys Conference and Banquet Center, 801 Health Park Boulevard, Grand Blanc township, MI 48439). Also calling in was Stephanie Sherer, the executive director of ASA. A longtime activist in the medical cannabis community, she provided many details to the upcoming challenge filed by ASA against the Federal Governments schedule 1 classification of marijuana. A special thanks to our in studio staff and other callers who participated in this informative and exciting show: Jamie Lowell, Peanut Butter, Greg Palowski, Pernell, Q tipper, Rick Thompson, Chad Carr, Kevin Spitler, Charme Gholson. Planet Green Trees is sponsored by” the Michigan Medical Marihuana Association-.michiganmedicalmarijuana.org and Komorn Law-18006563557. The archive to this episode can be found here: http://www.blogtalkr...am-l-courtney-s
       
      Michael A. Komorn
      Attorney and Counselor
       
      Email: michael@komornlaw.com
      Website: www.komornlaw.com
       
      Check out our Radio show:
      http://www.blogtalkr...lanetgreentrees
      CALL IN NUMBER: (347) 326-9626
      Live Every Thursday 8-10:00p.m.
       
      PLANET GREENTREES
      w/ Attorney Michael Komorn
       
      The most relevant radio talk show for the Michigan Medical Marijuana Community. PERIOD.
    • By Michael Komorn
      In the Federal Eastern District Court yesterday, Komorn Law and the MMMA filed a class action lawsuit on behalf of all medical marijuana patients and their caregivers who depend on the medical use of cannabis oil or products infused with marijuana, such as edible preparations. The lawsuit seeks to enjoin the Michigan State Police and Oakland County Sheriff’s Forensic Laboratories from creating reports falsely stating that medical marijuana preparations are a synthetic schedule 1 drug, with no medical use. The lawsuit also asks the Court to appoint a crime lab monitor to ensure that a scientific standard is applied at the labs for marijuana and its preparations.

      The class is represented by four plaintiffs, each one a previous defendant to criminal charges and asset forfeiture for possession of medical marijuana preparations.

      The named defendants of the lawsuit are Col. Kriste Kibbey Etue, Director of the Michigan State Police, Inspector Scott Marier, Interim Director of the Michigan State Police Forensic Science Division, Capt. Joe Quisenberry, Commanding Officer of the Forensic Services Laboratory for Oakland County, and Michael Bouchard, Sheriff of Oakland County, Michigan.

      Read the lawsuit and see the exhibits here: http://michiganmedicalmarijuana.org/uploads/Lorincz%20Federal%20Complaint%20and%20Exhibits.pdf

      FOX17 Coverage w/video: http://fox17online.com/2016/06/22/attorneys-file-federal-class-action-lawsuit-against-msp-crime-labs-over-marijuana-reporting-policy/
    • By trix
      The feds could actually soften their stance a little when it comes to weed.
       
      The Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification.
       
      FDA Press Officer Jeff Ventura described the review process, which is being completed at the request of the Drug Enforcement Agency, to The Huffington Post.
       
      "FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration, which is currently ongoing," Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule."
       
      The FDA could not confirm how long the review process would take.
       
      The U.S. has five "schedules" for drugs or chemicals that can be used to make drugs. Schedule I is reserved for drugs that the DEA considers to have the highest potential for abuse and no "current accepted medical use." Marijuana has been classified as Schedule I for decades, along with other substances like heroin and LSD. Rescheduling marijuana would not make it legal, but a lower schedule could potentially ease restrictions on research into the drug and make banks less wary of offering financial services to state-legal marijuana businesses. It could also allow those businesses to make some traditional tax deductions.
       
      "While DEA is the lead federal agency responsible for regulating controlled substances and enforcing the Controlled Substances Act, FDA, working with NIDA, provides scientific recommendations about the appropriate controls for those substances," FDA Deputy Director Doug Throckmorton said Friday in testimony delivered during the House Committee on Oversight and Government Reform hearing.
       
      "To make these recommendations, FDA is responsible for preparing what's called an eight-factor analysis, which is a document that is used to assess how likely a drug is to be abused," Throckmorton said.
       
      Here are the eight factors the FDA will consider about marijuana when deciding which schedule it should go under, according to the CSA:
      Its actual or relative potential for abuse Scientific evidence of its pharmacological effect, if known The state of current scientific knowledge regarding the drug or other substance Its history and current pattern of abuse The scope, duration, and significance of abuse What, if any, risk there is to the public health Its psychic or physiological dependence liability Whether the substance is an immediate precursor of a substance already controlled under this subchapter A DEA spokeswoman told HuffPost that the agency was required to order the FDA to review marijuana's scheduling status because of two public citizens' petitions that asked the agency for a review. A change could put marijuana in the company of cocaine and methamphetamine, two other Schedule II drugs.
       
      This isn't the first time the DEA has asked the FDA to reconsider marijuana, Throckmorton said Friday. In 2001 and 2006, the DEA requested an analysis of the drug after receiving other public petitions requesting that the agency reschedule it. But both times, federal regulators determined that marijuana should remain a Schedule I substance. At the time, the FDA said there simply wasn't enough research about marijuana's efficacy in treating various ailments.
       
      Part of the lack of cannabis science in the U.S. has to do with the federal stranglehold on marijuana research. There's only one federally legal marijuana garden in the U.S., at the University of Mississippi. The National Institute on Drug Abuse oversees the operation, and it's the only source of marijuana for federally sanctioned studies on the drug.
       
      To date, NIDA has conducted about 30 studies on the potential benefits of marijuana. Since 2003, it has approved more than 500 grants for marijuana-related studies, with a marked upswing in recent years, according to McClatchy. In 2003, 22 grants totaling $6 million were approved for cannabis research, McClatchy reported. In 2012, that number had risen to 69 approved grants totaling more than $30 million.
       
      Federal authorities have long been accused of only funding marijuana research that focuses on the potential negative effects of the substance. The DEA has also been accused of not acting quickly enough when petitioned to reschedule marijuana, and for obstructing science around the drug.
       
      Meanwhile, a number of recent studies have added to the growing body of research showing the medical potential of cannabis. Purified forms may attack some forms of aggressive cancer. Studies have tied marijuana use to blood sugar control and slowing the spread of HIV. One study found that legalization of the plant for medical purposes may even lead to lower suicide rates.
       
      Currently, 22 states and the District of Columbia have legalized marijuana for medical use, with New York state poised to be the 23rd. About ten other states have also legalized CBD-oil, a non-psychoactive ingredient in marijuana frequently used to treat epilepsy, for research or limited medical purposes.
       
      According to a recent CBS News poll, a vast majority of Americans -- over 80 percent -- approve of medical marijuana legalization.
       
      While the FDA isn't ready to get on board with legalization, it does seem more interested in the medical benefits of the drug.
       
      "The FDA has not approved marijuana as a safe and effective drug for any indication," the FDA stated in its latest guidelines regarding marijuana, posted Friday. "The FDA is aware that there is considerable interest in its use to attempt to treat a number of medical conditions, including, for example, glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders."

      http://www.huffingtonpost.com/2014/06/24/fda-marijuana_n_5526634.html
    • By trix
      Washington, D.C. -- Thirty members of Congress, led by Reps. Earl Blumenauer (D-Ore.), H. Morgan Griffith (R-Va.), Dana Rohrabacher (R-Calif.) and Jan Schakowsky (D-Ill.), sent a letter to Health and Human Services Secretary Sylvia Burwell on Tuesday demanding an end to the federal monopoly on marijuana research so that more studies can be done by scientists around the nation.
       
      "We write to express our support for increasing scientific research on the therapeutic risks and benefits of marijuana," the letter reads. "We ask that you take measures to ensure that any non-National Institutes of Health (NIH) funded researcher who has acquired necessary Food and Drug Administration (FDA), Institutional Review Board (IRB), Drug Enforcement Administration (DEA) and appropriate state and local authority approval be able to access marijuana for research at-cost without further review."

      Read More...


×
×
  • Create New...